Home › Oral Cancer › Michigan › Lansing
Oral Cancer clinical trials in Lansing, MI
4 studies for Oral Cancer are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- University of Michigan Health - Sparrow Lansing, Lansing
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- New York City, NY8 studies
- St. Louis, MO8 studies
- Chicago, IL8 studies
- Durham, NC7 studies
- Milwaukee, WI7 studies
- Kansas City, MO7 studies
- Pittsburgh, PA7 studies
- Ann Arbor, MI7 studies
- Houston, TX7 studies
- Richmond, VA7 studies
- Edison, NJ6 studies
Other studies in Lansing
- Lung Cancer11 studies
- Prostate Cancer10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)6 studies
- Laryngeal Cancer5 studies
- Bladder Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Colorectal Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colon Cancer4 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.